Device Trial Radar · NCT05874128
PROSPECTIVE EVALUATION OF HEARTFOCUS
Last checked: Nov 20, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
240
Actual
Start
Nov 13, 2023
Primary completion
Aug 16, 2024
Study completion Aug 16, 2024
Sponsor
- Lead sponsor
- DESKiNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 24, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study's objective is to evaluate if exams, performed with the HeartFocus software by novices, are of sufficient quality to visually analyze the left ventricular size, the left ventricular function, the right ventricular size, and the presence of non-trivial pericardial effusion. Novices will be nurses without prior ultrasound experience who have received dedicated training on cardiac ultrasound and on Heartfocus software. Ultrasound exams will be limited to the acquisition of 10 reference views
Conditions
- Cardiac Disease
Interventions
Using HeartFocus software with AI guidance (Novices)Device
The novice are nurses without prior ultrasound experience performed limited echocardiograms using the HeartFocus AI-based guidance software (DESKi). After a half-day training and practice on ≤9 patients, each novice acquired echocardiographic clips for 10 standard transthoracic views with the assistance of real-time software guidance and automated recording.
Using HeartFocus software without AI-guidanceDevice
Experienced sonographers and cardiologists performed limited echocardiograms using HeartFocus software, without AI assistance. The experts acquired echocardiographic sequences corresponding to the 10 standard transthoracic views, just like the novices.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Left Ventricular Size (Qualitative Visual Assessment)Time frame: Images evaluated by the cardiologists after the acquisition
- The Left Ventricular Function (Qualitative Visual Assessment)Time frame: Images evaluated by the cardiologists after the acquisition
- The Right Ventricle Size (Qualitative Visual Assessment)Time frame: Images evaluated by the cardiologists after the acquisition
1 more outcomes with a free account
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Lenox Hill Hospital
New York, New York
University Hospital of Bordeaux
Bordeaux, Aquitaine, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.